Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

Cardiovascular complications of pregnancy have risen substantially over the past decades,
and now account for the majority of pregnancy-induced maternal deaths, as well as having …

The aromatase-Cre recombinase (Cyp19-Cre) transgenic mouse model has been
extensively used for placenta-specific gene inactivation. In a pilot study, we observed …

Exosomes originating from human umbilical cord mesenchymal stem cells (hucMSC-exos)
have become a novel strategy for treating various diseases owing to their ability to regulate …

This review focuses on the management of reproductive issues in women who have
antiphospholipid syndrome (APS) or are carriers of antiphospholipid antibodies (aPL). The …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by pregnancy
morbidity or thrombosis and persistent antiphospholipid antibodies (aPL) that bind to the …

Antiphospholipid syndrome (APS) is a complex thrombo-inflammatory autoimmune disease
characterized by the presence of antiphospholipid antibodies (aPL). Women with APS are at …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
presence of pathogenic antiphospholipid antibodies (aPL). Since approximately 30 years …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
persistent presence of antibodies directed against phospholipids and phospholipid-binding …

In this study, we investigated the molecular differences between patients with typical
obstetric antiphospholipid syndrome (OAPS) and patients with non-criteria obstetric …